Copan Diagnostics, Inc.

Copan Diagnostics, Inc., a for-profit manufacturer of medical sampling and transport products headquartered in Murrieta, California, operates exclusively as a prime contractor supplying laboratory diagnostic products, flocked swabs, transport media, and specimen collection supplies to the federal government under full-and-open competition—no set-asides characterize the footprint. The vendor competes in NAICS 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers) and PSC codes covering laboratory equipment and supplies (562 awards) and medical and surgical instruments (151 awards).

The Defense Logistics Agency Troop Support Medical dominates Copan's customer base, representing 707 of 728 total awards (97% of award count) and $38.3 million of combined potential value. A single $200 million multiple-award IDIQ with the Federal Emergency Management Agency for COVID-19 response efforts anchors the top potential-value ranking, though no task orders against that vehicle appear in recent activity. The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response and five Veterans Integrated Service Network divisions within the Department of Veterans Affairs round out the active customer set; combined, non-DLA customers represent fewer than 1% of awards and roughly 9% of total combined potential value. DLA activity is sustained and granular—707 task orders against a single parent vehicle (Indefinite Delivery Contract SPE2DE, awarded June 16, 2022, ceiling $37.5 million, running through June 15, 2027) generate routine small-dollar delivery orders ranging from $143 to $2,121 per order.

Copan holds one active prime contract vehicle: the $37.5 million single-award IDIQ SPE2DE with DLA Troop Support Medical, under which 703 task orders have been placed. Work under this IDIQ covers laboratory products including reagents, diagnostics, chemicals, biologicals, apparatus, and equipment supporting U.S. military and federal healthcare programs. Recent delivery orders exemplify Copan's product mix—eSwabs with 1ML liquid Amies and regular flocked tips, universal transport medium (UTM) tubes without beads in bulk, 3ML medium collection tubes, liquid Amies media, regular polyester and flexible minitip flocked swabs, and plastic swab variants. Awards carry fixed-price structures with economic price adjustment provisions and are concentrated in the February 2025 through July 2026 window; all 14 awards visible in the source data carry completion dates between late July and early August 2026, creating a compressed recompete window for the underlying IDIQ (ultimate completion June 15, 2027). Activity has declined from 194 awards in 2024 to 102 in 2026 (year-to-date through mid-July), suggesting either demand normalization post-COVID or ordering pattern shifts within DLA.

Copan operates as a sole-source manufacturer into a narrow procurement stream: 99% of awards fund DLA Troop Support Medical, and the same single vehicle (SPE2DE) accounts for 703 of 705 tracked task orders. The vendor maintains no subcontract footprint and operates no partnerships visible in the federal award record. The $200 million FEMA COVID-19 multiple-award IDIQ represents strategic reserve capacity but has generated one recorded task order ($433 thousand) since 2020, indicating limited active engagement against that vehicle. Place of performance is Murrieta, California for all work visible in the source.